Invasive local recurrence increased after radiation therapy for ductal carcinoma in situ

American Journal of Surgery

Volumn 196, Issue 4, 2008, Pages 552-555

  Guerra, Lisa E ^a,b   Smith, Robina M ^b   Kaminski, Anna ^a,b   Lagios, Michael D ^c   Silverstein, Melvin J ^a,b  

^a Hoag Hospital   (United States)

^b UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^c Breast Cancer Consultation Service   (United States)

Author keywords

Ductal carcinoma in situ; Invasive recurrence; Radiation therapy

Indexed keywords

ARTICLE; CANCER PATIENT; CANCER RECURRENCE; CARCINOMA IN SITU; CONSERVATIVE TREATMENT; FEMALE; HUMAN; INTRADUCTAL CARCINOMA; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; PROSPECTIVE STUDY; TREATMENT INDICATION; TREATMENT OUTCOME;

BREAST NEOPLASMS; CARCINOMA, DUCTAL; FEMALE; HUMANS; NEOPLASM INVASIVENESS; NEOPLASM RECURRENCE, LOCAL; PREDICTIVE VALUE OF TESTS; PROSPECTIVE STUDIES; RISK FACTORS; TREATMENT OUTCOME;

EID: 52049120132     PISSN: 00029610     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjsurg.2008.06.008     Document Type: Article

References (12)

1. Silverstein M.J., Poller D., Craig P., et al. A prognostic index for ductal carcinoma in situ of the breast. Cancer 77 (1996) 2267-2274
2. Fisher B., Land S., Mamounas E., et al. Prevention of invasive breast cancer in women with ductal carcinoma in situ: an update of the National Surgical Adjuvant Breast and Bowel Project experience. Semin Oncol 28 (2001) 400-418
3. Bijker N., Meijnen P., Peterses J.L., et al. Breast-conserving treatment with or without radiotherapy in ductal carcinoma-in-situ: ten-year results of European Organisation for Research and Treatment of Cancer randomized phase III trial 10853-a study by the EORTC Breast Cancer Cooperative Group and EORTC Radiotherapy Group. J Clin Oncol 24 (2006) 3381-3387
4. Houghton J., George W.D., Cuzick J., et al. Radiotherapy and tamoxifen in women with completely excised ductal carcinoma in situ of the breast in the UK, Australia, and New Zealand: randomized controlled trial. Lancet 362 (2003) 95-102
5. Emdin S.O., Granstrand B., Ringberg A., et al. SweDCIS: radiotherapy after sector resection for ductal carcinoma in situ of the breast, results of a randomized trial in a population offered mammography screening. Acta Oncol 45 (2006) 536-543
6. Kestin L.L., Goldstein N.S., Martinez A.A., et al. Mammographically detected ductal carcinoma in situ treated with conservative surgery with or without radiation therapy. Ann Surg 2 (2000) 235-245
7. Macdonald H.R., Silverstein M.J., Mabry H., et al. Local control in ductal carcinoma in situ treated by excision alone: incremental benefit of larger margins. Am J Surg 190 (2005) 521-525
8. Hollingsworth A.B., Stough R.G., and O'Dell C.A. Breast magnetic resonance imaging for preoperative locoregional staging. Am J Surg (2008) epub
9. Fischer U., Zachariae O., Baum F., et al. The influence of preoperative MRI of the breasts on recurrence rate in patients with breast cancer. Eur Radiol 14 (2004) 1725-1731
10. Gorechlad J.W., McCabe E.B., Higgins J.H., et al. Screening for recurrences in patients with breast-conserving surgery: is there a role for MRI?. Ann Surg Oncol 15 (2008) 1703-1709
11. Belli P., Constantini M., Romani M., et al. Magnetic resonance imaging in breast cancer recurrence. Breast Cancer Res Treat 73 (2002) 223-235
12. Ralleigh G., Walker A.E., Hall-Craggs M.A., et al. MR imaging of the skin and nipple of the breast: differentiation between tumour recurrence and post-treatment change. Eur Radiol 11 (2001) 1651-1658